4-((5-chloropyrimidin-2-yl)oxy)-3-fluoroaniline | 110965-58-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-((5-chloropyrimidin-2-yl)oxy)-3-fluoroaniline
• 英文别名: 4-(5-Chloropyrimidin-2-yl)oxy-3-fluoroaniline；4-(5-chloropyrimidin-2-yl)oxy-3-fluoroaniline
• CAS: 110965-58-7
• 化学式: C₁₀H₇ClFN₃O
• 分子量: 239.636
• InChiKey: YPXWCACWXYFSJI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  61
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-nitrobenzoyl isocyanate 、 4-((5-chloropyrimidin-2-yl)oxy)-3-fluoroaniline 以 1,4-二氧六环 为溶剂， 生成 1-[4-(5-Chloro-pyrimidin-2-yloxy)-3-fluoro-phenyl]-3-(2-nitro-benzoyl)-urea
  参考文献：
  名称：

  Synthesis and Antitumor Activities of Novel Benzoylphenylurea Derivatives.

  摘要：

  合成了七十种新的苯甲酰苯基脲化合物，并对其在体内对P388白血病的抗肿瘤活性进行了研究。N-(2-硝基苯甲酰)-N'-[4-(2-吡啶基氧)苯基]脲在腹腔注射或口服给药时显示出最高的抗肿瘤活性。研究了它们的结构-活性关系，特别关注每个芳环上取代基的位置和种类。

  DOI：

  10.1248/cpb.39.2308
• 作为产物：
  描述：

  2,5-二氯嘧啶 、 4-氨基-2-氟苯酚 生成 4-((5-chloropyrimidin-2-yl)oxy)-3-fluoroaniline
  参考文献：
  名称：

  Synthesis and Antitumor Activities of Novel Benzoylphenylurea Derivatives.

  摘要：

  合成了七十种新的苯甲酰苯基脲化合物，并对其在体内对P388白血病的抗肿瘤活性进行了研究。N-(2-硝基苯甲酰)-N'-[4-(2-吡啶基氧)苯基]脲在腹腔注射或口服给药时显示出最高的抗肿瘤活性。研究了它们的结构-活性关系，特别关注每个芳环上取代基的位置和种类。

  DOI：

  10.1248/cpb.39.2308

文献信息

• [EN] hTERT MODULATORS AND METHODS OF USE<br/>[FR] MODULATEURS HTERT ET PROCÉDÉS D'UTILISATION
  申请人：UNIV ARIZONA

  公开号：WO2017095969A1

  公开（公告）日：2017-06-08

  The present invention provides hTERT modulators and methods for producing and using the same. In particular, the present invention provide a compound of the formula as described herein. Some aspects of the invention are based on the characterization of the effect of hTERT core promoter region mutants on the 5-12 G-quadruplex structure and its stability. It is believed that some of the compounds of the invention bind selectively to the G-quadruplex in the hTERT core promoter mutant, which results in reversal of the effect of mutant promoter activation.

  本发明提供hTERT调节剂及其生产和使用方法。具体来说，本发明提供了如下所述的一种化合物。该发明的一些方面基于对hTERT核心启动子区域突变体对5-12 G-四链结构及其稳定性影响的表征。据信，本发明的一些化合物选择性地结合到hTERT核心启动子突变体中的G-四链结构，从而逆转突变启动子激活的效果。
• hTERT modulators and methods of use
  申请人：Arizona Board of Regents on Behalf of the University of Arizona

  公开号：US10556860B2

  公开（公告）日：2020-02-11

  The present invention provides hTERT modulators and methods for producing and using the same. In particular, the present invention provide a compound of the formula as described herein. Some aspects of the invention are based on the characterization of the effect of hTERT core promoter region mutants on the 5-12 G-quadruplex structure and its stability. It is believed that some of the compounds of the invention bind selectively to the G-quadruplex in the hTERT core promoter mutant, which results in reversal of the effect of mutant promoter activation.

  本发明提供了 hTERT 调节剂及其生产和使用方法。特别是，本发明提供了如本文所述的式化合物。本发明的某些方面基于 hTERT 核心启动子区突变体对 5-12 G-四链结构及其稳定性影响的表征。据信，本发明的某些化合物可选择性地与 hTERT 核心启动子突变体中的 G-四叉体结合，从而逆转突变体启动子激活的效应。
• hTERT MODULATORS AND METHODS OF USE
  申请人：The Arizona Board of Regents On Behalf of the University of Arizona

  公开号：EP3383841A1

  公开（公告）日：2018-10-10
• Synthesis and Antitumor Activities of Novel Benzoylphenylurea Derivatives.
  作者：Hiroshi OKADA、Tohru KOYANAGI、Nobutoshi YAMDA、Takahiro HAGA

  DOI：10.1248/cpb.39.2308

  日期：——

  Seventy novel benzoylphenylurea compounds were synthesized and their antitumor activities were examined in vivo against P388 leukemia. N-(2-Nitrobenzoyl)-N'-[4-(2-pyrimidinyloxy)phenyl]ureas showed the highest antitumor activities when dosed intraperitoneally or orally. Their structure-activity relationships were examined with particular focus on the position and the variety of subsitituent on each aryl ring.

  合成了七十种新的苯甲酰苯基脲化合物，并对其在体内对P388白血病的抗肿瘤活性进行了研究。N-(2-硝基苯甲酰)-N'-[4-(2-吡啶基氧)苯基]脲在腹腔注射或口服给药时显示出最高的抗肿瘤活性。研究了它们的结构-活性关系，特别关注每个芳环上取代基的位置和种类。